Education, better prevention and the treatment of high blood pressure may be delaying seniors' signs of dementia and Alzheimer's, according to studies reported on in the New England Journal of Medicine.
Researchers say they are getting closer to proving that Alzheimer's disease and Type 2 diabetes might be one illness.
An international study has discovered a vascular issue that may contribute to Alzheimer's disease and other aging-related neurological disorders.
Seniors who take certain blood pressure medications might be at a dramatically reduced risk for developing dementia associated with Alzheimer's disease, according to findings in Neurology.
Meditation and yoga could become weapons in the fight against the advancement of dementia and Alzheimer's Disease in residents with mild cognitive impairment (MCI) according to new research.
Clinicians can use a new assessment to determine when an Alzheimer's patient is likely to need nursing home care, according to researchers based at Columbia University Medical Center.
Earlier this year, the Department of Health and Human Services released an action plan for tackling Alzheimer's diagnostics, treatment and funding.
Cognitive enhancers, such as donepezil or rivastigmine, do not improve function in those who have mild cognitive impairment over the long term, new research reveals.
Q: How did the book, which chronicles your mother's Alzheimer's disease, come to be? A: I started journaling and writing down what happened every time we were together. [I asked] what is good about this situation and where are the gifts and blessings? How can I stay connected with my mom through this journey?
Personalized programming is a hallmark of effective, enriching dementia care; providing what's needed becomes easier by knowing habits and preferences.
Residents of small assisted living communities are more likely to be younger than 65 and have a developmental disability or mental illness than those in a large community, according to newly published research.
Here we go again: This week saw the release of yet another breathless study claiming the cure for Alzheimer's disease is getting closer — maybe.
The largest-ever international study of Alzheimer's disease has significantly expanded the scientific community's understanding of the disease's genetic underpinnings, according to a report in Nature Genetics.
There was synergy between Dallas and Washington, D.C., on Tuesday. Prominent speakers at the LeadingAge conference in Dallas addressed what it means to age well and how people's understanding of aging is evolving — and their message happened to coincide with what experts said the same day at a Senate roundtable.
Vizamyl, a radioactive diagnostic drug, was approved by the Food and Drug Administration on Friday. The drug, also known as flutemetamol F 18 injection, is used with positron emission tomography imaging for adults being evaluation for Alzheimer's disease and dementia.
Seniors who take certain blood pressure medications might be at a dramatically reduced risk for developing dementia associated with Alzheimer's disease, according to findings published in the journal Neurology.
Nearly 100 million Americans are not taking medications as prescribed, leading to unnecessary deaths, hospitalizations and nursing home admissions. This is creating an impending care crisis as the population ages, according to a new report from the National Council on Patient Information and Education.
The discovery of a compound that stops diseases like Alzheimer's and Parkinson's in their tracks is a "landmark" step toward a pill to treat these conditions, according to researchers in the United Kingdom.
Effective pain management in long-term care is hampered by residents' attitudes and caregivers' misinterpretation of behaviors, according to newly published research in the journal Nursing Older People.
Better hygiene in developed countries correlates with a higher risk of developing Alzheimer's, researchers have discovered.
The Alzheimer's Drug Discovery Foundation will host its annual fall conference on Sept. 9-10 in Jersey City, NJ. The conference will bring together experts and scientists to present current drug discoveries and clinical development programs, pertaining to Alzheimer's.
Q: The Alzheimer's Association annual conference took place in mid-July. As an expert in the disease, what did you find the most noteworthy takeaway?
A friend who has spent a lifetime studying Alzheimer's disease once offered this double-edged observation: Once you make it to age 90, your odds of avoiding the disease dramatically improve.
More than 20 current and former workers at a Georgia Alzheimer's care facility face numerous criminal charges following a three-month investigation, the state's Bureau of Investigation announced Tuesday.
Q: Your new novel, "Life After Life," is set in a long-term care facility in North Carolina. Were you thinking of care workers reading the book? A: I finished the book and one of my earliest thoughts was, I hope I have done these people justice.
Lilly is upping its bet on Alzheimer's. The Indianapolis-based drug maker announced it has licensed experimental tracers that can hone in on and mark tau tangles that are believed to be a cause of the brain-degenerating disease.
A "breakthrough" Alzheimer's drug now looks much less promising after follow-up experiments failed to reproduce successful results, scientists recently announced. Non-standard use of the drug should be halted, they say.
A major breakthrough in Alzheimer's research could lead to new and more effective ways of treating the disease, according to a recently released study in the Journal of Neuroscience. Researchers at the Max Planck Florida Institute for Neuroscience may have discovered how the Amyloid beta peptide creates cognitive dysfunction.
Alzheimer's disease is very good at taking. It takes away memories. It takes away personalities. It can be argued that Alzheimer's essentially takes away a person's essence. And as almost anyone who has spent time in a senior living facility can tell you, it can also take away sexual inhibitions.
Virginia — State Sen. Bill Stanley (R) has introduced a bill requiring that nursing homes, assisted living facilities and other certified nursing facilities obtain minimum levels of insurance. If SB70 becomes law, affected facilities would have to maintain liability coverage of at least $1 million, and have levels of professional liability insurance defined by the state's medical malpractice caps.